BioMin Technologies Limited is a company that focuses on developing bioactive glass materials aimed at treating dentine hypersensitivity. Established to commercialise research conducted at Queen Mary University London and Imperial College, London, the company offers innovative solutions that cater primarily to the pharmaceutical industry.

Services include:
– Development of bioactive glass materials for oral health applications
– Solutions addressing dentine hypersensitivity
– Customisation of formulations to meet specific client needs
– Research and development in bioactive materials

BioMin Technologies Limited continues to drive advancements in dental care with its cutting-edge products and services. For more information, visit biomin.co.uk.